The Market for Rx-to-OTC Switches, 8th Edition
Description
The Market for Rx-to-OTC Switches, 8th Edition
More than 700 pharmaceutical products have made the switch from Rx to OTC over the past several decades. The U.S. Rx-to-OTC market has grown into a $13.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once available only by prescription.
Aging baby boomers, many of which are taking greater interest in their health, have created a growing Rx-to-OTC industry in America. This was reinforced by the pandemic, which presented patients with more selfcare due to lockdowns and mandates. It is anticipated that Rx-to-OTC switch products will continue to grow as interest from both consumers and developers continue to expand. Many of the new products that are on the market may be potential candidates after standing the test of time as a prescription product. Also, the demand for OTC products is not likely to diminish, giving rise to more possibilities in the switched categories. Over one third of American consumers use an OTC medication at least every other day and the numbers are increasing on a regular basis as more products appear on the OTC market.
The current climate of patient-consumer awareness of health issues is continuing to influence the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the counter. An increased focus on cost-savings, coupled with the effects of advertising and promotion, result in a higher rate of OTC purchases.
This report, The Market for Rx-to-OTC Switches, 8th Edition, analyses recent switches, products that are near switching. It estimates markets for switched products. Kalorama has examined this market in the past but this report reflects the most up-to-date analysis from Kalorama’s last report in 2017.
As part of its coverage, this report contains:
Issues and Trends Affecting The Rx-To-OTC Switches Market
Leading Participants
Information on the OTC industry
Overview Of The Over-The-Counter Drug Market
International Trends In Rx-To-OTC Switches
Markets by Category
Allergy, Cough, Cold, and Sinus Products: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Analgesics and Other Pain Relievers Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Anti-Infectives: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Gastrointestinal Drugs: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Smoking Cessation Products: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Other Drugs: Recent Switches, Overview, Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents)
Total Market: Market Size, Forecast, Market Share
Company Coverage
There are several companies that compete heavily in this market and use the Rx-to-OTC switch as a major part of their life-cycle management arsenal. Companies involved in the Rx-to-OTC switched market include brand, generic, and private label manufacturers. Competition will likely continue to be intense in the OTC market.
Consolidation remains a major factor in this market. Most major players have made a significant acquisition or formed a strategic alliance to increase revenues and drive growth. Product innovation, line extensions and strong promotional support are a few of the top strategies for growth in this industry.
More than 700 pharmaceutical products have made the switch from Rx to OTC over the past several decades. The U.S. Rx-to-OTC market has grown into a $13.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once available only by prescription.
Aging baby boomers, many of which are taking greater interest in their health, have created a growing Rx-to-OTC industry in America. This was reinforced by the pandemic, which presented patients with more selfcare due to lockdowns and mandates. It is anticipated that Rx-to-OTC switch products will continue to grow as interest from both consumers and developers continue to expand. Many of the new products that are on the market may be potential candidates after standing the test of time as a prescription product. Also, the demand for OTC products is not likely to diminish, giving rise to more possibilities in the switched categories. Over one third of American consumers use an OTC medication at least every other day and the numbers are increasing on a regular basis as more products appear on the OTC market.
The current climate of patient-consumer awareness of health issues is continuing to influence the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the counter. An increased focus on cost-savings, coupled with the effects of advertising and promotion, result in a higher rate of OTC purchases.
This report, The Market for Rx-to-OTC Switches, 8th Edition, analyses recent switches, products that are near switching. It estimates markets for switched products. Kalorama has examined this market in the past but this report reflects the most up-to-date analysis from Kalorama’s last report in 2017.
As part of its coverage, this report contains:
Issues and Trends Affecting The Rx-To-OTC Switches Market
Leading Participants
Information on the OTC industry
Overview Of The Over-The-Counter Drug Market
International Trends In Rx-To-OTC Switches
Markets by Category
Allergy, Cough, Cold, and Sinus Products: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Analgesics and Other Pain Relievers Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Anti-Infectives: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Gastrointestinal Drugs: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Smoking Cessation Products: Recent Switches, Market Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents), Conditions Information, Overview
Other Drugs: Recent Switches, Overview, Size, Forecast, Market Share, Brand vs. Switched Brands vs. Generics (Switched Equivalents)
Total Market: Market Size, Forecast, Market Share
Company Coverage
There are several companies that compete heavily in this market and use the Rx-to-OTC switch as a major part of their life-cycle management arsenal. Companies involved in the Rx-to-OTC switched market include brand, generic, and private label manufacturers. Competition will likely continue to be intense in the OTC market.
Consolidation remains a major factor in this market. Most major players have made a significant acquisition or formed a strategic alliance to increase revenues and drive growth. Product innovation, line extensions and strong promotional support are a few of the top strategies for growth in this industry.
Table of Contents
205 Pages
- Overview
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting the Rx-to-OTC Switches Market
- Leading Participants
- Overview of the Over-the-Counter Drug Market
- Distribution Channels
- Retail Market Value - OTC Drug Industry
- U.S. Drug Regulation
- Nonprescription Drug Safe Use Regulatory Expansion (NSURE)
- U.S. Demographics and the Non-Prescription Drug Market
- U.S. Health Spending Indicators
- International Trends in Rx-to-OTC Switches
- Overview
- Description of Conditions
- Product Analysis
- Recent Switch Activity
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Description of Conditions
- Product Analysis
- Recent Switch Activity
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Description of Conditions
- Product Analysis
- Recent Switch Activity
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Description of Conditions
- Product Analysis
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Description of Conditions
- Lung Cancer and Tobacco Use
- Product Analysis
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Description of Conditions
- Product Analysis
- Prescription Products with Anticipated OTC Approvals
- Market Analysis
- Competitive Analysis
- Overview
- Total Market Analysis
- Switch Forecast in the United States
- Competitive Analysis
- Naloxone Switch Encouraged by Congress
- Trends in Consumer Health Divisions
- Retail Strategies
- Mergers, Acquisitions and Partnerships
- Simultaneous Marketing – Prescription vs. OTC
- Impact on the Prescription Drug Manufacturer
- Direct-to-Consumer Advertising
- Patent Expiration
- Insurance Coverage for OTC Products
- Introduction
- Bayer AG
- GlaxoSmithKline
- Johnson & Johnson
- Perrigo Company plc
- Prestige Consumer Healthcare
- Proctor & Gamble
- Reckitt Benckiser
- Sanofi/Chattem
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
